From September 19th to 21st, 2025, the Fifth Children's Health Conference on the Integration of Chinese and Western Medicine will be held in Tianjin. The conference was co-sponsored by the China Association of Traditional Chinese Medicine, the China Medical Education Association, the Organizing Committee of the Children's Health Conference on the Integration of Chinese and Western Medicine and Tianjin University of Traditional Chinese Medicine. It brought together many experts and scholars in the field of pediatrics to discuss cutting-edge issues in the field of children's health. Changchun People's Pharmaceutical Group, as a well-known enterprise in the field of children's health, brought its starsThe product Tongkexin® pediatric pulmonary Cough Granules made a wonderful appearance.
During the conference, Changchun People's Pharmaceutical Group carefully arranged two special booths (main venue booth number: 14, sub-venue booth number: 37). The booth design is unique and ingenious, and the corporate image and product characteristics are displayed in a concise and clear style, which attracted the attention of many participants. The staff enthusiastically introduced the efficacy and advantages of Tongkexin® pediatric pulmonary cough granules, a golden product of the pediatric series, to the visitors, and explained in detail its unique role in the treatment of respiratory diseases in children. The interaction was frequent and the atmosphere was warm.
At the same time, at this meeting, the high-profile "Guidelines for the Diagnosis, Treatment and Evaluation of the Efficacy of Chinese and Western Medicine for Children with Cough after Infection" was officially released. The guide gathers the wisdom and hard work of many medical experts, and provides authoritative and scientific guidance for the diagnosis and treatment of cough in children after infection. Tongkexin® pediatric pulmonary cough granules are recommended by the guidelines for the treatment of cough with pulmonary qi deficiency syndrome after infection in children due to their spleen-strengthening, lung-nourishing, cough-relieving and asthma-relieving effects and their unique treatment mechanism and safety. This recommendation is not only a high recognition of Tongkexin® pediatric pulmonary cough granules, but also provides a valuable reference basis for pediatric clinical treatment and protects the health of children.
In parallel topic 1 of the Conference: The integration of China and the West, Breathing together, and creating the future, Professor Zhu Xiaohua of Jiangxi Children's Hospital also highly praised Tongkexin® pediatric pulmonary cough granules at the special meeting on “Diagnosis and Treatment Strategies for Respiratory Infectious Diseases in Children”. Combining his rich clinical experience, Professor Zhu elaborated in detail the pathogenesis characteristics and treatment difficulties of children's respiratory infectious diseases, and emphasized the importance of choosing safe and effective drugs in the treatment process. Professor Zhu mentioned that Tongkexin® pediatric pulmonary cough granules, as a drug designed for children, has a scientific and reasonable formula, fully taking into account the physiological characteristics and medication needs of children, and has a significant effect in children's respiratory diseases.
In parallel topic three of the conference: Healthy gastrointestinal tract and Vigorous growth, Professor Ye Liping of the Women's and Children's Medical Center Affiliated to Guangzhou Medical University analyzed the current respiratory infections facing pediatrics clinically at the special meeting on “Focusing on the gaps in Pediatric Medication and exploring new solutions for respiratory infections combined with gastrointestinal symptoms”.The number of children with combined gastrointestinal symptoms has increased, but there is a lack of overall treatment options. Professor Ye pointed out that Tongkexin® pediatric pulmonary cough granules, relying on its advantages of multi-target therapy, provide a new solution to this problem, and real-world research is being carried out to confirm the significance of Tongkexin® pediatric pulmonary cough granules in the treatment of respiratory infections combined with gastrointestinal symptoms.Curative effect. At the meeting, Professor Ye also shared a number of outstanding cases, vividly demonstrating the outstanding performance of Tongkexin® pediatric pulmonary cough granules in practical applications, which won high recognition and praise from the experts present.
At this meeting, Tongkexin® pediatric pulmonary cough granules not only shone in the field of treatment of respiratory diseases in children, but also made breakthroughs in the treatment of respiratory infections in children combined with gastrointestinal symptoms. In the future, Changchun People's Pharmaceutical Group will continue to uphold the concept of innovation and professional development, and continue to explore and expand the application field of children's medicines. The Group will continue to be committed to providing children with more comprehensive, high-quality, safe and effective medicines, helping the cause of children's health to a new level, and escorting the all-round development and healthy growth of children.
